Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
4.700
-0.600 (-11.32%)
Nov 4, 2025, 4:00 PM EST - Market closed
Genprex Market Cap
Genprex has a market cap or net worth of $4.72 million as of November 4, 2025. Its market cap has increased by 217.61% in one year.
Market Cap
4.72M
Enterprise Value
3.37M
1-Year Change
217.61%
Ranking
Category
Stock Price
$4.70
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $61.25M to $4.72M, a decrease of -92.29%. That is a compound annual growth rate of -28.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 4.72M | -34.85% |
| Dec 31, 2024 | 7.25M | -47.00% |
| Dec 29, 2023 | 13.67M | -80.37% |
| Dec 30, 2022 | 69.63M | 11.19% |
| Dec 31, 2021 | 62.63M | -64.95% |
| Dec 31, 2020 | 178.67M | 2,798.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |